Trial Profile
Efficacy and safety of TAS-102 by analyzing association of chemotherapy induced neutropenia (at 1 month mark) and overall survival in patients with refractory metastatic colorectal cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Aug 2016
Price :
$35
*
At a glance
- Drugs Tipiracil/trifluridine (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions; Therapeutic Use
- 23 Aug 2016 New trial record